Use access key #2 to skip to page content.

BlueCollarTrade (44.77)

February 2013

Recs

2

Getting Ready for Speculative Plays In the Next Earnings Cycle

February 24, 2013 – Comments (1) | RELATED TICKERS: AAPL , NFLX , PCLN

It is hard to hold stocks through earnings as you never really know which way the stock will run on that day.   The company can destroy on revenues, but miss on profits, or have record profits, but guide lower.  This can be frustrating. Very Very Frustrating.  I find it hard to know which stocks to buy for a good earnings beat, or even if I should hold a stock through earnings.    [more]

Recs

1

Profiting from a Sideways Moving Celgene

February 23, 2013 – Comments (1) | RELATED TICKERS: CELG

The fundamentally robust Celgene(NASDAQ: CELG) entered 2013 at $81 and has rocketed up to a high of $102.29 already this year.    On January 8th, The Biotechnology company gave a very rosy outlook out to 2017, and also announced positive trial results for some of its important experimental drugs.    Soon afterwards, the strong bullish push continued with a slew of analyst upgrades.   I believe Celgene will continued a bullish rise from here, but what other catalysts on the near horizon will send this stock to $110?  Are there any other buyers left right now to propel this stock?    [more]

Featured Broker Partners


Advertisement